Stock Events

Stock Events

Protagenic Therapeutics 

$0
24
-$0.02-85.86% Friday 14:14

Statistics

Day High
0.02
Day Low
0.02
52W High
0.02
52W Low
0.02
Volume
16,984
Avg. Volume
-
Mkt Cap
7,933.5
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3JunExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-1.37
-0.53
0.3
1.14
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-11.05MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PTIXW. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Alkermes
ALKS
Mkt Cap5.07B
Alkermes plc operates in the brain health area, including treatments for depression and schizophrenia, overlapping with Protagenic's focus on mental health disorders.
Acadia Pharmaceuticals
ACAD
Mkt Cap3.83B
ACADIA Pharmaceuticals specializes in central nervous system disorders, making it a direct competitor in the neurotherapeutics field.
BridgeBio Pharma
BBIO
Mkt Cap12.07B
BridgeBio Pharma targets genetic diseases and precisely engineered drugs that could compete with Protagenic's approach to treating mental health disorders.
Axsome Therapeutics
AXSM
Mkt Cap6.74B
Axsome Therapeutics develops novel therapies for central nervous system disorders including depression, directly competing with Protagenic's therapeutic focus.
Insmed
INSM
Mkt Cap40.44B
Insmed Incorporated works on rare diseases, including neurological disorders, potentially competing with Protagenic's research and development focus.
Neurocrine Biosciences
NBIX
Mkt Cap14.28B
Neurocrine Biosciences focuses on neurological and endocrine diseases, including treatments for mental health disorders, making it a competitor.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries has a broad portfolio that includes CNS treatments, potentially competing across several of Protagenic's target areas.

About

Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York.
Show more...
CEO
Dr. Garo H. Armen Ph.D.
Employees
1
Country
US
ISIN
US74365N1110

Listings

OTC Link
US
PTIX
OTC Link
US
PTIXW

0 Comments

Share your thoughts

FAQ

What is Protagenic Therapeutics stock price today?▼
The current price of PTIXW is $0 USD — it has decreased by -85.86% in the past 24 hours. Watch Protagenic Therapeutics stock price performance more closely on the chart.
What is Protagenic Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Protagenic Therapeutics stocks are traded under the ticker PTIXW.
What is Protagenic Therapeutics market cap?▼
Today Protagenic Therapeutics has the market capitalization of 7,933.5
When is the next Protagenic Therapeutics earnings date?▼
Protagenic Therapeutics is going to release the next earnings report on June 03, 2026.
What is Protagenic Therapeutics revenue for the last year?▼
Protagenic Therapeutics revenue for the last year amounts to 0 USD.
What is Protagenic Therapeutics net income for the last year?▼
PTIXW net income for the last year is -11.05M USD.
How many employees does Protagenic Therapeutics have?▼
As of April 02, 2026, the company has 1 employees.
In which sector is Protagenic Therapeutics located?▼
Protagenic Therapeutics operates in the Health Care sector.
When did Protagenic Therapeutics complete a stock split?▼
The last stock split for Protagenic Therapeutics was on March 23, 2023 with a ratio of 1:4.
Where is Protagenic Therapeutics headquartered?▼
Protagenic Therapeutics is headquartered in Santa Barbara, US.